Jan Makela - GE HealthCare President Imaging
| GEHC Stock | 82.00 2.90 3.42% |
President
Jan Makela is President Imaging of GE HealthCare Technologies
| Age | 55 |
| Address | 500 West Monroe Street, Chicago, IL, United States, 60661 |
| Phone | 833 735 1139 |
| Web | https://www.gehealthcare.com |
Latest Insider Transactions
Jan Makela Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jan Makela against GE HealthCare stock is an integral part of due diligence when investing in GE HealthCare. Jan Makela insider activity provides valuable insight into whether GE HealthCare is net buyers or sellers over its current business cycle. Note, GE HealthCare insiders must abide by specific rules, including filing SEC forms every time they buy or sell GE HealthCare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jan Makela over three months ago Disposition of 1929 shares by Jan Makela of GE HealthCare at 80.36 subject to Rule 16b-3 | ||
Jan Makela over six months ago Disposition of 20227 shares by Jan Makela of GE HealthCare at 63.51 subject to Rule 16b-3 |
GE HealthCare Management Efficiency
The company has return on total asset (ROA) of 0.0564 % which means that it generated a profit of $0.0564 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2185 %, meaning that it created $0.2185 on every $100 dollars invested by stockholders. GE HealthCare's management efficiency ratios could be used to measure how well GE HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, GE HealthCare's Return On Capital Employed is projected to slightly decrease based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.08, whereas Return On Equity is forecasted to decline to 0.14. At present, GE HealthCare's Intangibles To Total Assets are projected to slightly decrease based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.31, whereas Total Assets are forecasted to decline to about 30.4 B.Similar Executives
| Found 11 records | PRESIDENT Age | ||
| Alan Mateo | Veeva Systems Class | 62 | |
| Frederic Lequient | Veeva Systems Class | 51 | |
| Karen Akinsanya | Schrodinger | 56 | |
| Andrew Turitz | Teladoc | 51 | |
| Jonathan Faddis | Veeva Systems Class | 52 | |
| Thomas Schwenger | Veeva Systems Class | 56 | |
| Mike Walsh | Goodrx Holdings | N/A | |
| Gabriel Cappucci | Teladoc | 56 | |
| Bansi Nagji | Goodrx Holdings | 59 | |
| Eleni Zuppas | Veeva Systems Class | 54 | |
| Laizer Kornwasser | Teladoc | 53 | |
Management Performance
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0564 |
GE HealthCare Techno Leadership Team
Elected by the shareholders, the GE HealthCare's board of directors comprises two types of representatives: GE HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GEHC. The board's role is to monitor GE HealthCare's management team and ensure that shareholders' interests are well served. GE HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GE HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Catherine Estrampes, President Canada | ||
| Kenneth Stacherski, Chief Officer | ||
| Elie Chaillot, President Intercontinental | ||
| Kevin ONeill, President Diagnostics | ||
| Jahid Khandaker, Chief Officer | ||
| James Saccaro, VP CFO | ||
| Carolynne Borders, Chief Officer | ||
| Rana Strellis, Chief Officer | ||
| MS MD, Chief Officer | ||
| Robert Giglietti, Treasurer VP | ||
| Jan Makela, President Imaging | ||
| Roland Rott, President Ultrasound | ||
| Frank Esq, General Secretary | ||
| Peter Arduini, CEO President | ||
| Thomas Westrick, President Solutions | ||
| Betty Larson, Chief Officer | ||
| Adam Holton, Chief Officer | ||
| George Newcomb, Controller Officer |
GEHC Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GE HealthCare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0564 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 44.65 B | ||||
| Shares Outstanding | 456.87 M | ||||
| Shares Owned By Insiders | 3.08 % | ||||
| Shares Owned By Institutions | 83.51 % | ||||
| Number Of Shares Shorted | 8.28 M | ||||
| Price To Book | 4.50 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether GE HealthCare Techno offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GE HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ge Healthcare Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ge Healthcare Technologies Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GE HealthCare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GE HealthCare. If investors know GEHC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GE HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.242 | Dividend Share 0.12 | Earnings Share 3.65 | Revenue Per Share 42.916 | Quarterly Revenue Growth 0.009 |
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GE HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.